Omnicell, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OMCL research report →
About the company
Omnicell, Inc. , together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.
- CEO
- Randall A. Lipps
- IPO
- 2001
- Employees
- 3,580
- HQ
- Fort Worth, TX, US
Price Chart
- Market Cap
- $1.96B
- P/E
- 96.72
- P/S
- 1.60
- P/B
- 1.55
- EV/EBITDA
- 14.98
- Div Yield
- 0.00%
- Gross Margin
- 43.50%
- Op Margin
- 2.83%
- Net Margin
- 1.67%
- ROE
- 1.64%
- ROIC
- 1.22%
- Revenue
- $1.18B · 6.53%
- Net Income
- $2.05M · -83.62%
- EPS
- $0.04 · -83.48%
- Op Income
- $11.66M
- FCF YoY
- -42.56%
- 52W High
- $55.00
- 52W Low
- $26.85
- 50D MA
- $41.66
- 200D MA
- $39.11
- Beta
- 0.97
- Avg Volume
- 622.88K
Get TickerSpark's AI analysis on OMCL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Njoku Nnamdi | other | 3,660 |
| May 18, 26 | Njoku Nnamdi | sell | 3,090 |
| May 15, 26 | NUTT BRIAN H. | other | 226 |
| May 15, 26 | Manley Corey J | other | 4,041 |
| May 18, 26 | Manley Corey J | sell | 5,025 |
| May 15, 26 | LIPPS RANDALL A | other | 12,347 |
| Apr 1, 26 | Njoku Nnamdi | other | 46,296 |
| Apr 1, 26 | Manley Corey J | other | 25,132 |
| Apr 1, 26 | LIPPS RANDALL A | other | 90,939 |
| Apr 1, 26 | Radford Harlan Baird | other | 37,037 |
Our OMCL coverage
Recent articles, reports, and earnings notes.
No research on OMCL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OMCL report →Similar companies
Peers in the same neighborhood.